Interesting Engineering on MSN4d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Medscape5d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
WebMD2d
FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
With more people needing daily insulin, biosimilar options can make this lifesaving treatment more accessible. Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to ...
Becker's Hospital Review4d
FDA OKs 1st rapid-acting insulin biosimilar
Sanofi-Aventis' Merilog is the first FDA-approved rapid-acting insulin biosimilar. On Feb. 14, the agency approved the drug, a biosimilar to Novolog, for glycemic control improvement in adult and ...
Endocrinology Advisor3d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Monthly Prescribing Reference5d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The rapid-acting insulin should be administered subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks, or upper arm. The dosage is based on the patient’s ...
U.S. News & World Report3d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes By Stephanie Brown HealthDay Reporter WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug ...
Yahoo Finance8d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar ...
MedPage Today9d
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
Opens in a new tab or window The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced ...
KTEN4d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...